UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest reported) July 24, 2003
---------------
TheraSense, Inc.
--------------------------
(Exact name of registrant as specified in its chapter)
Delaware 000-33139 94-3267373
---------------------------------- ------------------ ---------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation File Number) Identification No.)
1360 South Loop Road, Alameda, California 94502
----------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (510) 749-5400
-----------------
Not Applicable
----------------------------------------------------------------------
(Former name or former address, if changed since last report)
ITEM 7: FINANCIAL STATEMENTS AND EXHIBITS
(c) Exhibits
99.1 Earnings Press Release, dated July 24, 2003
ITEM 9: REGULATION FD DISCLOSURE
On July 24, 2003 the Company announced its financial results for the
Quarter ended June 30, 2003. A copy of the press release containing the
announcement is included as Exhibit 99.1 to this Current Report and is
incorporated herein by reference. The Company does not intend for this exhibit
to be incorporated by reference into future filings under the Securities
Exchange Act of 1934. The foregoing information is provided pursuant to Item 12
(Results of Operations and Financial Condition) of Form 8-K.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: July 24, 2003 THERASENSE, INC.
By: /s/ W. MARK LORTZ
-------------------------------------
W. Mark Lortz
President, Chief Executive Officer
and Chairman
2